| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 259 | 92 | 3 |
| Full Text Views | 13 | 8 | 0 |
| PDF Downloads | 13 | 10 | 0 |
Efficacy and Tolerance of Praziquantel in Patients with Schistosoma Mansoni Infection and Symmers' Fibrosis: a Field Study in the Sudan
Ultrasonography was used in a village in the Gezira-Managil scheme in the Sudan to identify patients with Symmers' fibrosis. In a random sample from patients with active Schistosoma mansoni infection, 238 patients were found to have no liver involvement while 59 had Symmers' periportal fibrosis. Patients were treated with a single dose of 40 mg/kg body weight of praziquantel. Six months after dosing, 51% and 58% were cured of the infection with 81% and 84% reduction in egg burden in the Symmers' and non-Symmers' patients, respectively. The drug was equally well tolerated by the two groups. It is concluded that patients with Symmers' fibrosis respond to praziquantel and tolerate the drug in a similar manner to patients without Symmers'.